News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
53,797 Results
Type
Article (697)
Press Release (53100)
Section
Business (18561)
Career Advice (9)
Deals (3379)
Drug Delivery (1)
Drug Development (12134)
Employer Resources (2)
FDA (1838)
Job Trends (1893)
News (33754)
Policy (2087)
Tag
Academia (69)
Accelerated approval (1)
Allergies (17)
Alliances (1824)
ALS (12)
Alzheimer's disease (172)
Antibody-drug conjugate (ADC) (9)
Approvals (1874)
Artificial intelligence (20)
Autoimmune disease (1)
Bankruptcy (12)
Best Places to Work (1959)
BIOSECURE Act (1)
Biosimilars (4)
Biotechnology (2)
Bladder cancer (31)
Brain cancer (5)
Breast cancer (61)
Cancer (438)
Cardiovascular disease (21)
Career advice (9)
Career pathing (1)
CAR-T (17)
Cell therapy (55)
Cervical cancer (1)
Clinical research (10724)
Collaboration (76)
Compensation (5)
Complete response letters (1)
COVID-19 (324)
CRISPR (3)
C-suite (18)
Cystic fibrosis (15)
Data (574)
Depression (2)
Diabetes (37)
Diagnostics (566)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (11)
Duchenne muscular dystrophy (13)
Earnings (15799)
Editorial (1)
Employer resources (2)
Events (8345)
Executive appointments (48)
FDA (2164)
Funding (56)
Gene editing (7)
Generative AI (1)
Gene therapy (35)
GLP-1 (42)
Government (223)
Guidances (82)
Healthcare (1521)
IgA nephropathy (5)
Immunology and inflammation (9)
Indications (6)
Infectious disease (344)
Inflammatory bowel disease (27)
Influenza (8)
Intellectual property (10)
IPO (2237)
Job creations (85)
Job search strategy (9)
Kidney cancer (4)
Layoffs (7)
Legal (109)
Liver cancer (6)
Lung cancer (78)
Lymphoma (38)
Machine learning (1)
Manufacturing (14)
MASH (15)
Medical device (1330)
Medtech (1330)
Mergers & acquisitions (1248)
Metabolic disorders (91)
Multiple sclerosis (21)
NASH (2)
Neurodegenerative disease (10)
Neuropsychiatric disorders (1)
Neuroscience (253)
NextGen: Class of 2025 (306)
Non-profit (77)
Obesity (43)
Opinion (4)
Ovarian cancer (18)
Pain (12)
Pancreatic cancer (13)
Parkinson's disease (32)
Patents (19)
Patient recruitment (15)
Peanut (10)
People (1907)
Pharmaceutical (2)
Phase I (2819)
Phase II (4717)
Phase III (4224)
Pipeline (418)
Policy (2)
Postmarket research (319)
Preclinical (795)
Prostate cancer (22)
Radiopharmaceuticals (29)
Rare diseases (46)
Real estate (53)
Recruiting (1)
Regulatory (2039)
Reports (4)
Research institute (80)
Rett syndrome (3)
RSV (9)
Schizophrenia (11)
Series A (4)
Series B (4)
Sickle cell disease (9)
Spinal muscular atrophy (25)
Sponsored (1)
Startups (71)
State (1)
Supply chain (4)
Tariffs (1)
Vaccines (75)
Weight loss (8)
Women's health (4)
Date
Today (55)
Last 7 days (242)
Last 30 days (612)
Last 365 days (4965)
2025 (2027)
2024 (5036)
2023 (5434)
2022 (5889)
2021 (6010)
2020 (5159)
2019 (3292)
2018 (2521)
2017 (2634)
2016 (1928)
2015 (2720)
2014 (1570)
2013 (903)
2012 (976)
2011 (1234)
2010 (1079)
Location
Africa (21)
Alabama (5)
Arizona (11)
Arkansas (1)
Asia (1486)
Australia (341)
California (1066)
Canada (157)
China (20)
Colorado (46)
Connecticut (50)
Delaware (32)
Europe (4889)
Florida (156)
Georgia (37)
Idaho (1)
Illinois (74)
India (1)
Indiana (84)
Japan (24)
Kansas (9)
Kentucky (1)
Louisiana (1)
Maine (5)
Maryland (188)
Massachusetts (809)
Michigan (35)
Minnesota (89)
Mississippi (1)
Missouri (5)
Nebraska (1)
Nevada (19)
New Hampshire (9)
New Jersey (419)
New York (341)
North Carolina (126)
Northern California (452)
Ohio (28)
Pennsylvania (265)
Rhode Island (1)
South America (34)
Southern California (432)
Tennessee (13)
Texas (231)
United States (4194)
Utah (33)
Virginia (23)
Washington D.C. (6)
Washington State (95)
Wisconsin (11)
53,797 Results for "k2m".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Chimerix Announces Updated Phase 2 Response Assessment of Dordaviprone in Recurrent H3 K27M Glioma at the 2024 SNO Meeting
November 11, 2024
·
4 min read
Policy
Lilly’s Zepbound Wins NICE Backing for Obese Patients With Very High BMI
The U.K.’s National Institute for Health and Care Excellence has endorsed the use of Eli Lilly’s Zepboundfor weight management in patients with BMI of 35 kg/m2 and above and at least one weight-related comorbidity.
June 5, 2024
·
2 min read
·
Tristan Manalac
Policy
K2M (KTWO) Alert: Johnson Fistel Investigates Proposed Sale of K2M Group Holdings, Inc.; Are Shareholders Getting a Fair Deal?
Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of K2M Group Holdings, Inc.
August 30, 2018
·
1 min read
Policy
K2M GROUP INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of K2M Group Holdings, Inc. - KTWO
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of K2M Group Holdings, Inc. (“K2M”) (NasdaqGS: KTWO) to Stryker Corporation
August 30, 2018
·
1 min read
Policy
WeissLaw LLP Investigates K2M Group Holdings, Inc. Acquisition
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of K2M Group Holdings, Inc.
August 30, 2018
·
1 min read
Business
K2M & Brainlab Cooperate Towards an Adapted Version of K2M Spinal Systems Compatible with Brainlab Navigation
The two companies will collaborate in the commercial release of future navigated K2M spinal systems, which would be compatible with Brainlab spinal navigation systems.
October 26, 2017
·
9 min read
Policy
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of K2M Group Holdings, Inc. - KTWO
Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating K2M Group Holdings, Inc.
September 27, 2018
·
2 min read
Pharm Country
Click Therapeutics Secures $30M in Growth Capital from K2 HealthVentures to Expand Operations
Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ solutions as prescription medical treatments, today announced $30 million in debt financing from K2 HealthVentures (K2HV), a healthcare-focused specialty finance company, to accelerate commercialization of its leading smoking cessation solution, Clickotine™, and to advance its pipeline of clinically-validated digital therapeutics. “This financing will hel
December 1, 2020
·
3 min read
BioCapital
K2M Announces Completion of 300 RHINE Cervical Disc System Surgical Cases
K2M to feature its RHINE Cervical Disc System, industry-leading 3D-printed portfolio, & Balance ACS® Platform at the 2017 Meeting of the German Spine Society.
November 30, 2017
·
10 min read
Press Releases
HighField Biopharmaceuticals Files INDs for Two ADCplex™ Immunoliposomes with Different Cancer Killing Payloads to Overcome Limitations of Current ADCs
April 21, 2025
·
2 min read
1 of 5,380
Next